Liposomal Irinotecan and Veliparib in Treating Patients With Solid Tumors
Clinical trial NCT02631733 · COMPLETED
Trial details
- NCT number
- NCT02631733
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-31
- Primary completion
- 2019-11-21
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.